___

As near­ly 10,000 fresh­men and trans­fers arrived on cam­pus at the Uni­ver­si­ty of Cal­i­for­nia, Los Ange­les, last fall, they were invit­ed to try some­thing nev­er before offered dur­ing stu­dent ori­en­ta­tion: depres­sion screen­ing.

The hope, admin­is­tra­tors explained, is that by iden­ti­fy­ing their risk for depres­sion, stu­dents can get the sup­port they need before they face the rig­ors of acad­e­mia and the dis­ori­ent­ing expe­ri­ence of liv­ing away at col­lege. Read the rest of this entry »

___

The Pentagon’s Push to Pro­gram Sol­diers’ Brains (The Atlantic):

“…darpa offi­cials refer to the poten­tial con­se­quences of neu­rotech­nol­o­gy by invok­ing the acronym elsi, a term of art devised for the Human Genome Project. It stands for “eth­i­cal, legal, social impli­ca­tions.” The man who led the dis­cus­sion on ethics among the research teams Read the rest of this entry »

___

Lim­it­ing children’s screen time linked to bet­ter cog­ni­tion, study says (CNN):

“Lim­it­ing kids’ recre­ation­al screen time to less than two hours a day, along with suf­fi­cient sleep and phys­i­cal activ­i­ty, is asso­ci­at­ed with improved cog­ni­tion, accord­ing to a study pub­lished in The Lancet Child & Ado­les­cent Health.

The study includ­ed about 4,500 US chil­dren ages 8 to 11 and mea­sured their habits against the Cana­di­an 24-Hour Move­ment Guide­lines for Chil­dren and Youth. It found that Read the rest of this entry »

—

Six break­through neu­rotech start-ups win cov­et­ed Ontario Brain Insti­tute award (press release):

“Canada’s most pres­ti­gious ear­ly-stage neu­rotech­nol­o­gy entre­pre­neur awards were announced today by the Ontario Brain Insti­tute (OBI). The ONtre­pre­neurs pro­gram, the sin­gle largest fun­der of ear­ly-stage neu­rotech entre­pre­neurs in Cana­da, is invest­ing in six ear­ly-stage ven­tures this year to help accel­er­ate their path to com­mer­cial­iza­tion through access to fund­ing, resources, and men­tor­ship Read the rest of this entry »

___

Helius Med­ical Tech­nolo­gies and HealthTech Con­nex Announce Alliance to Build Cana­di­an Com­mer­cial Infra­struc­ture (press release):

“Helius Med­ical Tech­nolo­gies, Inc. (NASDAQ:HSDT) (TSX:HSM), a neu­rotech com­pa­ny focused on neu­ro­log­i­cal well­ness, today announced that the Com­pa­ny has entered into an agree­ment with HealthTech Con­nex, Inc. (“HTC”) to devel­op and man­age neu­ro­plas­tic­i­ty clin­ics in Cana­da. Read the rest of this entry »